Lindsay Androski

Insider Reports History

Location
Watertown, MA
Signature
/s/ David C. Hastings as attorney-in-fact for Lindsay Androski
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lindsay Androski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eloxx Pharmaceuticals, Inc. Director Restricted Stock Units 3,750 $5,400 $0.7200 24 Jan 2025 Direct
Arbutus Biopharma Corp President and CEO, Director Stock Option (Right to Buy) 310,422 18 Mar 2025 Direct
Eloxx Pharmaceuticals, Inc. Director Common Stock 15,750 24 Jan 2025 Direct

Insider Reports Filed by Lindsay Androski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABUS Arbutus Biopharma Corp 18 Mar 2025 1 $0 4 President and CEO, Director 20 Mar 2025, 16:08
ABUS Arbutus Biopharma Corp 24 Feb 2025 0 $0 3 President and CEO, Director 06 Mar 2025, 16:08
ELOX Eloxx Pharmaceuticals, Inc. 24 Jan 2025 2 $0 4 Director 28 Jan 2025, 17:35
ELOX Eloxx Pharmaceuticals, Inc. 16 Oct 2024 1 $0 4 Director 17 Oct 2024, 16:01
ELOX Eloxx Pharmaceuticals, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 16:32
ELOX Eloxx Pharmaceuticals, Inc. 30 Jan 2023 1 $0 4 Director 31 Jan 2023, 15:07
ELOX Eloxx Pharmaceuticals, Inc. 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 21:50
ELOX Eloxx Pharmaceuticals, Inc. 01 Jul 2022 0 $0 3 Director 06 Jul 2022, 21:49